NORMAL SITUATION

Kinesitherapie Blomme

Company — Normal situation.

Financial year 2022 · Closed on 31/12/2022

Net result86 k €+352,3 %over 1 year
Gross margin124,9 k €+258,0 %over 1 year
Equity652,8 k €-35,3 %over 1 year

Identity

Source · BCE/KBO

Kinesitherapie Blomme is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0427.701.209
Legal form
Private company with limited liability
Contributed capital
756 166,85 €
Latest accounts
31/12/2022
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 39 filings

Trend over 18 financial years

20222022202120202019
Income statement
Gross margin124,9 k €34,9 k €133,4 k €23,3 k €25,3 k €
EBITDA124,9 k €34,6 k €132,5 k €22,3 k €24,8 k €
Operating result124,8 k €31,4 k €129,2 k €17 k €9,9 k €
Net result86 k €19 k €81,2 k €14,9 k €6,6 k €
Balance sheet
Equity652,8 k €1 M €989,8 k €908,6 k €893,6 k €
Total assets663,9 k €1 M €1 M €920,6 k €901,1 k €
Cash29,4 k €162,7 k €139,2 k €10,7 k €7,3 k €
Debts11,1 k €11,8 k €17,7 k €12,1 k €7,5 k €

Board of directors

Source · NBB, accounts to 31/12/2022

1 active · 3 ended

Active mandates

Jan Blomme

Liquidator

Active

Ended mandates

Carmen Noyelle

Associate

Ended
Jan Blomme

Director

Ended
Jan Blomme

Manager

Ended

Full financial information

Source · NBB
202220222021202020192018
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year10/12/202201/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202209/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year1 months12 months12 months12 months12 months12 months
Filing date20/07/202320/07/202313/07/202202/07/202129/06/202025/07/2019
General meeting––24/05/202215/06/202124/05/202029/06/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 39 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/2022—20/07/2023DutchPDF
Micro model09/12/2022—20/07/2023DutchPDF
Micro model31/12/202124/05/202213/07/2022DutchPDF
Micro model31/12/202015/06/202102/07/2021DutchPDF
Micro model31/12/201924/05/202029/06/2020DutchPDF
Micro model31/12/201829/06/201925/07/2019DutchPDF
Micro model31/12/201701/07/201830/07/2018DutchPDF
Micro model31/12/201624/06/201712/07/2017DutchPDF
Abridged model31/12/201524/05/201630/06/2016DutchPDF
Abridged model31/12/201430/06/201529/07/2015DutchPDF
Abridged model31/12/201324/05/201425/06/2014DutchPDF
Abridged model31/12/201205/07/201329/07/2013DutchPDF
Abridged model31/12/201129/06/201226/07/2012DutchPDF
Abridged model31/12/201028/06/201120/07/2011DutchPDF
Abridged model31/12/200924/05/201022/06/2010DutchPDF
Abridged model31/12/200830/06/200927/07/2009DutchPDF
Abridged model31/12/200724/05/200813/06/2008DutchPDF
Abridged model31/12/200624/05/200718/06/2007DutchPDF
Abridged model31/12/200524/05/200623/06/2006DutchPDF
Abridged model31/12/200424/05/200524/06/2005DutchPDF
Abridged model31/12/200324/06/200402/07/2004DutchPDF
Abridged model31/12/200214/06/200330/06/2003DutchPDF
Abridged model31/12/200124/05/200204/09/2002DutchPDF
Abridged model31/12/200025/05/200103/12/2001DutchPDF

View all 39 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2022

1 active · 3 ended

Active mandates

Jan Blomme

Liquidator

Active

Ended mandates

Carmen Noyelle

Associate

Ended
Jan Blomme

Director

Ended
Jan Blomme

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution05/01/2024
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Dissolution10/01/2023
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares12/02/2018
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares14/03/2014
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares06/04/2006
    BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ALGEMENE VERGADERING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2022
    Annual accounts 202286 k €↑
  2. 2022
    Annual accounts 202219 k €↓
  3. 2022
    Name changeKINESITHERAPIE BLOMME in vereffening
  4. 2021
    Annual accounts 202181,2 k €↑
  5. 2021
    Name changeKINESITHERAPIE BLOMME
  6. 2020
    Annual accounts 202014,9 k €↑
  7. 2019
    Annual accounts 20196,6 k €↓
  8. 2018
    Annual accounts 20186,7 k €↑
  9. 2017
    Annual accounts 20171,6 k €↓
  10. 2016
    Annual accounts 201610,6 k €↑
  11. 2015
    Annual accounts 20155,3 k €↓
  12. 2014
    Annual accounts 201412,6 k €↓
  13. 2013
    Annual accounts 201323,5 k €↓
  14. 2012
    Annual accounts 201236,9 k €↓
  15. 2011
    Annual accounts 201146,8 k €↑
  16. 2010
    Annual accounts 201035,6 k €↑
  17. 2009
    Annual accounts 200915,2 k €↓
  18. 2008
    Annual accounts 200825,4 k €↓
  19. 2007
    Annual accounts 200726,8 k €↑
  20. 2006
    Annual accounts 200622,9 k €